GoodRx Holdings, Inc. - Class A Common Stock (GDRX)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / Class A Common Stock
Shares outstanding
108M
Number of holders
163
Total 13F shares, excl. options
132M
Shares change
+3.03M
Total reported value, excl. options
$1.03B
Value change
+$24.3M
Put/Call ratio
1.09
Number of buys
79
Number of sells
-65
Price
$7.80

Significant Holders of GoodRx Holdings, Inc. - Class A Common Stock (GDRX) as of Q2 2024

194 filings reported holding GDRX - GoodRx Holdings, Inc. - Class A Common Stock as of Q2 2024.
GoodRx Holdings, Inc. - Class A Common Stock (GDRX) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 132M shares .
Largest 10 shareholders include Francisco Partners Management, LP (70.1M shares), VANGUARD GROUP INC (8.13M shares), AMERIPRISE FINANCIAL INC (5.18M shares), MILLENNIUM MANAGEMENT LLC (4.12M shares), Rubric Capital Management LP (3.74M shares), LAKEWOOD CAPITAL MANAGEMENT, LP (3.6M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (2.95M shares), Petrus Trust Company, LTA (2.65M shares), and AMERICAN CENTURY COMPANIES INC (2.33M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.